Ingevity Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
14.4%projected annual EPS growth
Analyst Coverage
3analysts covering
Monitoring Framework
Key Performance Indicators
Adjusted EBITDA from continuing operations Quarterly91.5MTarget: $370 million to $395 million
Net Sales from continuing operations Quarterly258MTarget: $1.05 billion to $1.15 billion
Adjusted Diluted EPS from continuing operations Quarterly115.0%Target: $4.70 to $5.20
Free Cash Flow (excluding BASF litigation payment) Quarterly
Net Debt Ratio QuarterlyTarget: 2.0x to 2.5x
Watch Items
- BASF litigation settlement paymentTrigger: Pre-tax payment of approximately $113.2 million in Q2 2026
Research as of 20 Jun 2026